Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Capital Expenditures (2018 - 2025)

Exagen's Capital Expenditures history spans 8 years, with the latest figure at $624000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 79.31% year-over-year to $624000.0; the TTM value through Dec 2025 reached $641000.0, down 10.6%, while the annual FY2025 figure was $641000.0, 10.6% down from the prior year.
  • Capital Expenditures reached $624000.0 in Q4 2025 per XGN's latest filing, up from $17000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.9 million in Q2 2022 to a low of -$1.3 million in Q4 2021.
  • Average Capital Expenditures over 5 years is $327700.0, with a median of $181500.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: crashed 537.56% in 2021, then soared 7250.0% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at -$1.3 million in 2021, then soared by 132.32% to $406000.0 in 2022, then plummeted by 73.89% to $106000.0 in 2023, then surged by 228.3% to $348000.0 in 2024, then surged by 79.31% to $624000.0 in 2025.
  • Per Business Quant, the three most recent readings for XGN's Capital Expenditures are $624000.0 (Q4 2025), $17000.0 (Q3 2025), and -$113000.0 (Q2 2025).